1[1]Sanchez J, Volquez C, Totten PA, et al. The etiology and man agement of genital ulcers in the Dominican Republic and Peru.[J]. Sex Transm Dis, 2002, 29(10) :559-567.
2[3]Suligoi B, Dorrucci M, Volpi A, et al. Prevalence and determi nants of herpes simplex virus type 2 infection in a cohort of HIV positive individuals in Italy [ J]. Sex Transm Dis, 2002, 29 ( 11 ) :665-667.
3[4]Schacker T, Zeh J, Hu H, et al. Changes in plasma human im munodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression [ J]. J Infect Dis, 2002, 186(12): 1718-1725.
4[5]Mihret W, Rinke de Wit TF, Petros B, et al. Herpes simplex vi rus type 2 seropositivity among urban adults in Africa: results from two cross-sectional surveys in Addis Ababa, Ethiopia[ J]. Sex Transm Dis, 2002, 29(3) :175-181.
5[6]Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994 [J]. N Engl J Med, 1997, 337(16) :1105-1111.
6[7]Smith JS, Herrero R, Munoz N, et al. Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines [ J ]. Sex Transm Dis, 2001, 28 (4) :187 ～ 194.
7[8]Laccano-Ponce E, Smith JS, Munoz N, et al. High prevalence of antibodies to herpes simplex virus type 2 among middle-aged women in Mexico City, Mexico: a population-based study [ J ]. Sex Transm Dis, 2001,28 (5) :270-276.
8[9]Patrick DM, Dawar M, Cook DA, et al. Antenatal seroprevalence of herpes simplex virus type 2 ( HSV-2 ) in Canadian women: HSV 2 prevalence increases throughout the reproductive years[ J ]. Sex Transm Dis, 2001, 28 ( 7 ) :424 -428.
9[10]Laubereau B, Zwahlen M, Neuenschchwander B, et al. Herpes simplex virus type 1 and 2 in Switzerland [ J ]. Schweiz Med Wochenschr, 2000, 130 (5): 143-150.
10[11]Patel R. Progress in meeting today's demands in genital herpes: an overview of current management. [ J]. J Infect Dis, 2002, 15; 186 Suppl 1 :S47-56.
